Gut microbiota mediates cognitive impairment in young mice after multiple neonatal exposures to sevoflurane

Meiyu Liu1,2, Shaoyong Song1, Qingcai Chen1

  • 1Department of Anesthesiology, First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

Aging
|June 28, 2021
PubMed

Insights

Repeated anesthesia exposure in newborns may harm cognitive development. This study shows sevoflurane alters gut bacteria, causing cognitive deficits in mice, suggesting a link between gut microbiota and neurotoxicity.

Area of Science:

  • Neuroscience
  • Microbiology
  • Developmental Toxicology

Background:

  • Anesthesia exposure in early life is a potential risk factor for cognitive impairment.
  • The underlying mechanisms, particularly the role of gut microbiota, are not well understood.

Purpose of the Study:

  • To investigate the impact of multiple sevoflurane exposures on gut microbiota in neonatal mice.
  • To determine if microbiota alterations contribute to sevoflurane-induced cognitive impairment.

Main Methods:

  • Neonatal mice were exposed to sevoflurane multiple times.
  • Cognitive function was assessed.
  • Gut microbiota composition was analyzed using sequencing.
  • Fecal microbiota transplantation was performed to establish causality.

Main Results:

  • Sevoflurane exposure led to cognitive impairment and significant changes in gut microbiota composition.
  • Fecal transplantation from exposed mice to naive mice replicated cognitive deficits.
  • Specific bacterial taxa, including Streptococcus and Lachnospiraceae, were differentially abundant and linked to cognitive health.

Conclusions:

  • Alterations in gut microbiota composition are a key factor in sevoflurane-induced cognitive impairment in young mice.
  • Targeting the gut microbiota may offer a therapeutic strategy for sevoflurane-related neurotoxicity.

Related Concept Videos